Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Target price




24.09.21 / Frankfurt WKN: A2AD5S / Symbol: NRIFF / Name: Nuvo Pharmaceuticals / Stock / Pharmaceuticals / Micro Cap /
Latest predictions
Your prediction

Nuvo Pharmaceuticals Inc. Stock

There is an upward development for Nuvo Pharmaceuticals Inc. compared to yesterday, with an increase of €0.020 (2.250%).
With 0 Sell predictions and 1 Buy predictions the community sentiment towards the Nuvo Pharmaceuticals Inc. stock is not clear.
With a target price of €1.00 there is a slightly positive potential of 9.890% for Nuvo Pharmaceuticals Inc. compared to the current price of €0.91.
Our community identified positive and negative aspects for Nuvo Pharmaceuticals Inc. stock for the coming years. 1 users see the criterium "Business model" as a plus for the Nuvo Pharmaceuticals Inc. stock. On the other hand our users think that "Market Position" could be a problem in the future.

Pros and Cons of Nuvo Pharmaceuticals Inc. in the next few years

Future proof or reliable business model
Could be worthwhile Investment >10% per year
Below average Marketposition
Higher risks for its business

Performance of Nuvo Pharmaceuticals Inc. vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
Nuvo Pharmaceuticals Inc. 2.250% -0.546% 5.814% 102.222% 46.774% -48.295% -80.954%
NeutriSci International Inc -5.420% -4.778% -21.408% -30.250% -23.562% - -
BELLUS Health Inc. -0.090% 5.750% 87.586% 193.243% 124.174% - -
ChroMedX Corp. -1.910% 10.574% 14.019% 20.000% -0.543% - -

Other discussions about Nuvo Pharmaceuticals Inc. Stock

New thread Forum